Victoza
These highlights do not include all the information needed to use VICTOZA safely and effectively. See full prescribing information for VICTOZA.VICTOZA (liraglutide) injection, for subcutaneous useInitial U.S. Approval: 2010
Approved
Approval ID
1d18f106-0584-4fee-97ab-32771a64b809
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Feb 6, 2023
Manufacturers
FDA
A-S Medication Solutions
DUNS: 830016429
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
liraglutide
PRODUCT DETAILS
NDC Product Code50090-2853
Application NumberNDA022341
Marketing CategoryC73594
Route of AdministrationSUBCUTANEOUS
Effective DateJune 10, 2022
Generic Nameliraglutide
INGREDIENTS (7)
LIRAGLUTIDEActive
Quantity: 6 mg in 1 mL
Code: 839I73S42A
Classification: ACTIB
PHENOLInactive
Quantity: 5.5 mg in 1 mL
Code: 339NCG44TV
Classification: IACT
PROPYLENE GLYCOLInactive
Quantity: 14 mg in 1 mL
Code: 6DC9Q167V3
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: CNTM
SODIUM PHOSPHATE, DIBASIC, DIHYDRATEInactive
Quantity: 1.42 mg in 1 mL
Code: 94255I6E2T
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: CNTM